Charles River Laboratories | CRL - 债务

股票价格
166.97
每天变化
3.13 1.91%
每月一次
-3.21%
每年
42.84%
Q2 预测
166.17


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.4B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


债务 更改 日
Agilent USD 3.35B 55M 2025-09
Align Technology USD 114.45M 6.82M 2025-12
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.01B 426.8M 2025-09
Cardinal Health USD 8.92B 111M 2026-03
Charles River Laboratories USD 2.63B 157.4M 2025-09
Cigna USD 31.46B 2.58B 2025-12
Concord Medical Services Hldg CNY 3.01B 27.15M 2023-06
CVS Health USD 64.57B 1.27B 2025-12
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.48B 14M 2025-09
Elevance Health USD 31.84B 204M 2026-03
Galapagos EUR 7.5M 3.36M 2025-09
Humana USD 13.99B 1.62B 2026-03
Illumina USD 2.55B 23M 2025-12
Incyte USD 40.41M 855K 2025-12
Intrexon USD 0 13.82M 2024-06
IQVIA Holdings USD 15.72B 767M 2025-12
Laboratory Of America USD 6.53B 3.9M 2025-12
Lonza CHF 4.71B 915M 2024-12
McKesson USD 9.79B 141M 2025-09
Merck EUR 12.1B 2.7B 2025-09
Mettler Toledo International USD 2.21B 25.94M 2025-09
Novartis USD 35.38B 2.74B 2025-12
Pfizer USD 60.85B 78M 2025-09
Quest Diagnostics USD 6.41B 179M 2026-03
Revvity USD 3.37B 5.86M 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
United Therapeutics USD 200M 100M 2025-03
UnitedHealth USD 77.92B 472M 2026-03
Veradigm USD 200.33M 431K 2022-09
Waters USD 1.49B 52.2M 2025-09
West Pharmaceutical Services USD 202.8M 0 2026-03